![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Stryker Wins Expanded CE Mark for Stent Retriever
Stryker Wins Expanded CE Mark for Stent Retriever
![](https://www.fdanews.com/ext/resources/test/Device_Images3/Stryker-1.gif?t=1497997363&width=430)
Stryker won an expanded CE Mark for its Trevo stent retriever, a thrombectomy device used as a front-line treatment for acute ischemic stroke.
The expanded indication increases the previously cleared treatment window by 18 hours to 24 hours, following a similar action by the FDA in February.
Clinical trial data showed that patients treated with the Trevo retriever in the six- to 24-hour window were almost four times as likely to be functionally independent at 90 days post stroke.
Upcoming Events
-
21Oct